Near-Infrared Dyes And Conjugates For Targeting Tumors (2025)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,752,023 | Near-Infrared Dyes And Conjugates For Targeting Tumors In force · Medium confidence | Lahjavida, Inc. | In force | Medium confidence | ||
| Application 18/869,200 | Near-Infrared Dyes And Conjugates For Targeting Tumors Pending Not granted | Lahjavida, Inc. | Pending | Not granted | ||
| Application 19/035,666 | Prodrugs Based On Tumor Targeting Near Infrared Dye-Drug Conjugates (DDC) Pending Not granted | Lahjavida, Inc. | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Lahjavida, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.